RecruitingPhase 4NCT04040452
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
Studying Periodontal Ehlers-Danlos syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Phoenix Children's Hospital
- Principal Investigator
- Kevin Engelhardt, MDHeart Center
- Intervention
- Continuous ketorolac(drug)
- Enrollment
- 166 enrolled
- Eligibility
- All sexes
- Timeline
- 2021 – 2026
Study locations (1)
- Phoenix Children's Hospital, Phoenix, Arizona, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04040452 on ClinicalTrials.govOther trials for Periodontal Ehlers-Danlos syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07528547Hypersight and Ethos In Pediatric RadiotherapyUniversity Health Network, Toronto
- RECRUITINGPHASE4NCT06590402Anterior Femoral and Adductor Canal Nerve Blocks in Peds KneesHospital for Special Surgery, New York
- RECRUITINGPHASE3NCT06739122A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)Eli Lilly and Company
- RECRUITINGPHASE3NCT05261139EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe DiseasePfizer